Testing effectiveness (Phase 2)Study completedNCT02240459
What this trial is testing
Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment
Who this might be right for
Overactive BladderMild Cognitive Impairment
University of Alberta 47